Avidity Biosciences, Inc.RNAEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| FMR LLC | 14.04% | 10.4M | — | 2024-02-09 |
| RTW Investments, LP | 9.99% | 12.1M | flat | 2024-08-23 |
| T. ROWE PRICE ASSOCIATES, INC. | 9.00% | 10.6M | ▼ -3.10pp | 2024-11-14 |
| BlackRock, Inc. | 8.80% | 6.5M | — | 2024-01-25 |
| Avoro Capital Advisors LLC | 8.30% | 9.9M | — | 2024-11-14 |
| The Vanguard Group | 7.84% | 9.2M | flat | 2024-11-12 |
| Wellington Management Group LLP | 5.97% | 7.0M | — | 2024-11-08 |
| NOS. OF ABOVE PERSONS | 5.40% | 6.3M | ▲ +0.30pp | 2024-11-14 |
| STATE STREET CORPORATION | 4.64% | 5.4K | — | 2024-01-23 |
| Bristol-Myers Squibb Company | 4.30% | 5.1M | — | 2024-11-13 |
| Cowen Financial Products LLC | 0.00% | 5.4K | ▼ -7.60pp | 2024-11-13 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-02-27 | Hughes Steven George | Chief Medical Officer | Disposition | 115.9K | — | — |
| 2026-02-27 | Tamar Thompson | Director | Disposition | 6.7K | — | — |
| 2026-02-27 | Sarah Boyce | President and CEO | Disposition | 474.9K | — | — |
| 2026-02-27 | MacLean Michael F | Chief Financial Officer | Disposition | 134.0K | — | — |
| 2026-02-27 | Simona Skerjanec | Director | Disposition | 6.7K | — | — |
| 2026-02-27 | McCarthy Teresa | Chief Human Resources Officer | Disposition | 165.3K | — | — |
| 2026-02-27 | Moriarty John B | Chief Legal Officer | Disposition | 92.1K | — | — |
| 2026-02-27 | WILSON TROY EDWARD | Director | Disposition | 65.1K | — | — |
| 2026-02-27 | WILSON TROY EDWARD | Director | Disposition | 13.7K | — | — |
| 2026-02-27 | Flanagan W. Michael | Chief Scientific Officer | Disposition | 150.4K | — | — |
1–10 of 19
Page 1 / 2